- Home
- FMS vs HOLX Comparison
FMS vs HOLX Comparison
Compare FMS & HOLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FMS
- HOLX
- Stock Information
- Founded
- FMS 1996
- HOLX 1985
- Country
- FMS Germany
- HOLX United States
- Employees
- FMS 109916
- HOLX N/A
- Industry
- FMS Misc Health and Biotechnology Services
- HOLX Medical Electronics
- Sector
- FMS Health Care
- HOLX Health Care
- Exchange
- FMS Nasdaq
- HOLX Nasdaq
- Market Cap
- FMS 14.1B
- HOLX 16.5B
- IPO Year
- FMS 1996
- HOLX 1990
- Fundamental
- Price
- FMS $23.99
- HOLX $74.10
- Analyst Decision
- FMS Sell
- HOLX Hold
- Analyst Count
- FMS 2
- HOLX 15
- Target Price
- FMS $30.00
- HOLX $79.00
- AVG Volume (30 Days)
- FMS 439.9K
- HOLX 4.9M
- Earning Date
- FMS 11-04-2025
- HOLX 11-03-2025
- Dividend Yield
- FMS 2.38%
- HOLX N/A
- EPS Growth
- FMS 8.40
- HOLX N/A
- EPS
- FMS 2.86
- HOLX 2.49
- Revenue
- FMS $23,046,819,198.00
- HOLX $4,100,500,000.00
- Revenue This Year
- FMS $1.75
- HOLX $6.23
- Revenue Next Year
- FMS $3.01
- HOLX $5.37
- P/E Ratio
- FMS $16.47
- HOLX $29.76
- Revenue Growth
- FMS 2.10
- HOLX 1.74
- 52 Week Low
- FMS $21.06
- HOLX $51.90
- 52 Week High
- FMS $30.46
- HOLX $80.75
- Technical
- Relative Strength Index (RSI)
- FMS 27.16
- HOLX 70.04
- Support Level
- FMS $23.50
- HOLX $73.86
- Resistance Level
- FMS $24.63
- HOLX $74.28
- Average True Range (ATR)
- FMS 0.40
- HOLX 0.25
- MACD
- FMS -0.41
- HOLX -0.05
- Stochastic Oscillator
- FMS 12.31
- HOLX 29.07
About FMS Fresenius Medical Care AG
Fresenius Medical Care is the largest dialysis company in the world, treating about 300,000 patients from nearly 3,700 clinics worldwide as of December 2024. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.
About HOLX Hologic Inc.
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.